{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:11:49Z","timestamp":1793797909086,"version":"4.6.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:00:00Z","timestamp":1569283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","award":["PUE0102"],"award-info":[{"award-number":["PUE0102"]}],"id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003074","name":"Ministry of Science, Technology and Productive Innovation, Argentina | Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","award":["PICT2015-2036"],"award-info":[{"award-number":["PICT2015-2036"]}],"id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Allende, Fundaci\u00f3n Roemmers, Universidad Austral- Argentina"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41434-019-0102-7","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:03:53Z","timestamp":1569341033000},"page":"62-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Human umbilical cord perivascular cells-derived extracellular vesicles mediate the transfer of IGF-I to the liver and ameliorate hepatic fibrogenesis in mice"],"prefix":"10.1038","volume":"27","author":[{"given":"Esteban","family":"Fiore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana M.","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Bayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Malvicini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Atorrasagasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8999-5347","authenticated-orcid":false,"given":"Mariana","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-5483","authenticated-orcid":false,"given":"Gustavo","family":"Yannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Mazzolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"102_CR1","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u201341.","journal-title":"Gut"},{"key":"102_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005;115:209\u201318.","journal-title":"J Clin Invest"},{"key":"102_CR3","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1478-3231.2010.02428.x","volume":"31","author":"K Bonefeld","year":"2011","unstructured":"Bonefeld K, Moller S. Insulin-like growth factor-I and the liver. Liver Int. 2011;31:911\u20139.","journal-title":"Liver Int"},{"key":"102_CR4","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1053\/gast.1997.v113.pm9352873","volume":"113","author":"I Castilla-Cortazar","year":"1997","unstructured":"Castilla-Cortazar I, Garcia M, Muguerza B, Quiroga J, Perez R, Santidrian S, et al. Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology. 1997;113:1682\u201391.","journal-title":"Gastroenterology"},{"key":"102_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jhep.2005.03.025","volume":"43","author":"M Conchillo","year":"2005","unstructured":"Conchillo M, de Knegt RJ, Payeras M, Quiroga J, Sangro B, Herrero JI, et al. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. J Hepatol. 2005;43:630\u20136.","journal-title":"J Hepatol"},{"key":"102_CR6","doi-asserted-by":"publisher","first-page":"e0162955","DOI":"10.1371\/journal.pone.0162955","volume":"11","author":"L Sobrevals","year":"2016","unstructured":"Sobrevals L, Enguita M, Quiroga J, Prieto J, Fortes P. Insulin-like growth factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats. PLoS ONE. 2016;11:e0162955.","journal-title":"PLoS ONE"},{"key":"102_CR7","first-page":"912","volume":"51","author":"L Sobrevals","year":"2010","unstructured":"Sobrevals L, Rodriguez C, Romero-Trevejo JL, Gondi G, Monreal I, Paneda A, et al. Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats. Hepatology. 2010;51:912\u201321.","journal-title":"Hepatology"},{"key":"102_CR8","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jhep.2011.10.026","volume":"56","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Iredale JP. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J Hepatol. 2012;56:1417\u20139.","journal-title":"J Hepatol"},{"key":"102_CR9","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","volume":"60","author":"F Tacke","year":"2014","unstructured":"Tacke F, Zimmermann HW. Macrophage heterogeneity in liver injury and fibrosis. J Hepatol. 2014;60:1090\u20136.","journal-title":"J Hepatol"},{"key":"102_CR10","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3748\/wjg.v24.i23.2427","volume":"24","author":"EJ Fiore","year":"2018","unstructured":"Fiore EJ, Dominguez LM, Bayo J, Garcia MG, Mazzolini GD. Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: cells and extracellular vesicles as therapeutic strategies. World J Gastroenterol. 2018;24:2427\u201340.","journal-title":"World J Gastroenterol"},{"key":"102_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"102_CR12","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499\u2013506.","journal-title":"Blood"},{"issue":"3","key":"102_CR13","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/liv.12338","volume":"34","author":"Juan Bayo","year":"2013","unstructured":"Bayo J, Marrodan M, Aquino JB, Silva M, Garcia MG, Mazzolini G. The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma. Liver Int. 2013;34:330\u201342.","journal-title":"Liver International"},{"key":"102_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s12015-015-9585-9","volume":"11","author":"EJ Fiore","year":"2015","unstructured":"Fiore EJ, Mazzolini G, Aquino JB. Mesenchymal stem\/stromal cells in liver fibrosis: recent findings, old\/new caveats and future perspectives. Stem Cell Rev. 2015;11:586\u201397.","journal-title":"Stem Cell Rev"},{"key":"102_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, Bohm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9:12.","journal-title":"Cell Commun Signal."},{"key":"102_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1634\/stemcells.2004-0166","volume":"23","author":"R Sarugaser","year":"2005","unstructured":"Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells. 2005;23:220\u20139.","journal-title":"Stem Cells"},{"key":"102_CR17","doi-asserted-by":"publisher","first-page":"837420","DOI":"10.1155\/2014\/837420","volume":"2014","author":"J Bayo","year":"2014","unstructured":"Bayo J, Fiore E, Aquino JB, Malvicini M, Rizzo M, Peixoto E, et al. Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor. Biomed Res Int. 2014;2014:837420.","journal-title":"Biomed Res Int"},{"key":"102_CR18","doi-asserted-by":"publisher","first-page":"e95171","DOI":"10.1371\/journal.pone.0095171","volume":"9","author":"J Bayo","year":"2014","unstructured":"Bayo J, Fiore E, Aquino JB, Malvicini M, Rizzo M, Peixoto E, et al. Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma. PLoS ONE. 2014;9:e95171.","journal-title":"PLoS ONE"},{"key":"102_CR19","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/scd.2014.0174","volume":"24","author":"EJ Fiore","year":"2015","unstructured":"Fiore EJ, Bayo JM, Garcia MG, Malvicini M, Lloyd R, Piccioni F, et al. Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice. Stem Cells Dev. 2015;24:791\u2013801.","journal-title":"Stem Cells Dev"},{"key":"102_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13287-016-0424-y","volume":"7","author":"E Fiore","year":"2016","unstructured":"Fiore E, Malvicini M, Bayo J, Peixoto E, Atorrasagasti C, Sierra R, et al. Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells. Stem Cell Res Ther. 2016;7:172.","journal-title":"Stem Cell Res Ther"},{"key":"102_CR21","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/scd.2016.0349","volume":"26","author":"GD Kusuma","year":"2017","unstructured":"Kusuma GD, Carthew J, Lim R, Frith JE. Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunities to engineer the therapeutic effect. Stem Cells Dev. 2017;26:617\u201331.","journal-title":"Stem Cells Dev"},{"key":"102_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nri855","volume":"2","author":"C Thery","year":"2002","unstructured":"Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2:569\u201379.","journal-title":"Nat Rev Immunol"},{"key":"102_CR23","doi-asserted-by":"publisher","first-page":"26913","DOI":"10.3402\/jev.v3.26913","volume":"3","author":"J Lotvall","year":"2014","unstructured":"Lotvall J, Hill AF, Hochberg F, Buzas EI, Di Vizio D, Gardiner C, et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.","journal-title":"J Extracell Vesicles"},{"key":"102_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","volume":"6","author":"D Ha","year":"2016","unstructured":"Ha D, Yang N, Nadithe V. Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges. Acta Pharmaceutica Sinica B. 2016;6:287\u201396.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"102_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/acsnano.6b07607","volume":"11","author":"JP Armstrong","year":"2017","unstructured":"Armstrong JP, Holme MN, Stevens MM. Re-engineering extracellular vesicles as smart nanoscale therapeutics. ACS Nano. 2017;11:69\u201383.","journal-title":"ACS Nano"},{"key":"102_CR26","doi-asserted-by":"crossref","first-page":"13048","DOI":"10.18632\/oncotarget.14369","volume":"8","author":"Q Liu","year":"2017","unstructured":"Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, et al. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Oncotarget. 2017;8:13048\u201358.","journal-title":"Oncotarget"},{"key":"102_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1073\/pnas.1522297113","volume":"113","author":"DK Kim","year":"2016","unstructured":"Kim DK, Nishida H, An SY, Shetty AK, Bartosh TJ, Prockop DJ. Chromatographically isolated CD63+CD81+ extracellular vesicles from mesenchymal stromal cells rescue cognitive impairments after TBI. Proc Natl Acad Sci USA. 2016;113:170\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"102_CR28","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.5966\/sctm.2015-0341","volume":"5","author":"LR Braid","year":"2016","unstructured":"Braid LR, Hu WG, Davies JE, Nagata LP. Engineered mesenchymal cells improve passive immune protection against lethal venezuelan equine encephalitis virus exposure. Stem Cells Transl Med. 2016;5:1026\u201335.","journal-title":"Stem Cells Transl Med"},{"key":"102_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013;22:845\u201354.","journal-title":"Stem Cells Dev"},{"key":"102_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13287-016-0453-6","volume":"8","author":"L Chen","year":"2017","unstructured":"Chen L, Xiang B, Wang X, Xiang C. Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure. Stem Cell Res Ther. 2017;8:9.","journal-title":"Stem Cell Res Ther"},{"key":"102_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/sctm.16-0226","volume":"6","author":"H Haga","year":"2017","unstructured":"Haga H, Yan IK, Takahashi K, Matsuda A, Patel T. Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice. Stem Cells Transl Med. 2017;6:1262\u201372.","journal-title":"Stem Cells Transl Med"},{"key":"102_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/scrt465","volume":"5","author":"CY Tan","year":"2014","unstructured":"Tan CY, Lai RC, Wong W, Dan YY, Lim SK, Ho HK. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther. 2014;5:76.","journal-title":"Stem Cell Res Ther"},{"key":"102_CR33","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/jcmm.13208","volume":"21","author":"G Lou","year":"2017","unstructured":"Lou G, Yang Y, Liu F, Ye B, Chen Z, Zheng M, et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J Cell Mol Med. 2017;21:2963\u201373.","journal-title":"J Cell Mol Med"},{"key":"102_CR34","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu Y, Zhang Q, Cai X, Li F, Ma Z, Xu M, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J Cell Mol Med. 2017;21:2491\u2013502.","journal-title":"J Cell Mol Med"},{"key":"102_CR35","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","volume":"428","author":"S Keerthikumar","year":"2016","unstructured":"Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428:688\u201392.","journal-title":"J Mol Biol"},{"key":"102_CR36","doi-asserted-by":"publisher","first-page":"e42662","DOI":"10.1371\/journal.pone.0042662","volume":"7","author":"O Treacy","year":"2012","unstructured":"Treacy O, Ryan AE, Heinzl T, O\u2019Flynn L, Cregg M, Wilk M, et al. Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation. PLoS ONE. 2012;7:e42662.","journal-title":"PLoS ONE"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0102-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0102-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41434-019-0102-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:14:07Z","timestamp":1684617247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-019-0102-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,24]]},"references-count":36,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["102"],"URL":"https:\/\/doi.org\/10.1038\/s41434-019-0102-7","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,24]]},"assertion":[{"value":"15 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}